FAQ: Branded Legacy's New Vancouver Facility for Addiction Treatment Solutions
Summary
What is the main announcement in this content?
Branded Legacy’s subsidiary BioLegacy Evaluative Group has acquired a 22,000-square-foot commercial property in Vancouver, Canada to serve as a laboratory and manufacturing hub for addiction treatment solutions and harm reduction technologies.
Where is the new facility located and why is this location significant?
The facility is located in Vancouver, Canada, strategically positioned in the center of Vancouver’s drug crisis, which enables BioLegacy to collaborate directly with affected populations while advancing their technologies.
What are the key features of the new facility?
The facility is GMP-compliant and equipped with ISO Class 7 and 8 clean rooms, designed to support the development of safe, effective devices and products for addiction treatment and harm reduction.
Who are the academic partners mentioned in the content?
BioLegacy is advancing technologies supported by partnerships with McMaster University and Stanford University’s Dr. Eran Bendavid.
What is Branded Legacy’s focus and what products do they develop?
Branded Legacy is a biotechnology company focused on addiction treatment and harm reduction, developing innovative solutions including a patented intranasal naloxone delivery device for opioid overdose treatment and nasal delivery platforms for vaccines and medications.
What is the significance of this acquisition for Branded Legacy’s operations?
This acquisition provides a dedicated manufacturing and laboratory hub that will support the development of safe, effective devices and products designed to counteract hazardous substances and reduce associated harms in addiction treatment.
Where can I find more information about Branded Legacy?
For more information, visit the company’s website at https://BrandedLegacy.com or view the full press release at https://ibn.fm/lX2Sc.
What is the stock symbol for Branded Legacy?
Branded Legacy trades on the OTC market under the symbol BLEG.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 196403